Why the study?
Does whole-body 3.0-T MRI detect subclinical muscle pathology and correlate with clinical manifestations in patients with primary dysferlinopathies?
Population
6 German patients with primary dysferlinopathies defined by absence of dysferlin expression in muscle
Design
Case_series
Authors
Loading...
May support MRI characterization of dysferlinopathies; case-report evidence leaves open routine diagnostic adoption.
Does whole-body 3.0-T MRI detect subclinical muscle pathology and correlate with clinical manifestations in patients with primary dysferlinopathies?
Whole-body 3.0-T MRI is a useful non-invasive tool for detecting subclinical muscle pathology and differentiating primary dysferlinopathies from other muscular dystrophies.
Kesper et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: